Observational study demonstrates that desidustat improves haemoglobin in kidney transplant anaemia, suggesting a viable option.
Treatment with desidustat resulted in improvement in haemoglobin levels with acceptable tolerability over short-term follow-up similar to erythropoietin. The convenience of oral administration supports its potential role as a patient-centred option for anaemia management following kidney transplantation.
No takes yet. Share an insight, caveat, or question.
Barak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: